lecture 19 - anticoagulants

Upload: api-3703352

Post on 30-May-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 Lecture 19 - Anticoagulants

    1/43

    %&%$

    %#%$

    %!%%#&$

  • 8/14/2019 Lecture 19 - Anticoagulants

    2/43

    ,02489,88 8 90 ,77089 41 -44/ 488 1742 ,

    /,2,0/ ;0880 %8 :8:, 3;4;08

    , 4.,0/ ;,84.43897.943

    - 5,9009 ,/0843 ,3/ ,.9;,943

    . -44/ .4,:,943

  • 8/14/2019 Lecture 19 - Anticoagulants

    3/43

    $06:03.041;03983420489,88

  • 8/14/2019 Lecture 19 - Anticoagulants

    4/43

    %0 1472,943 41 ,3 :3,390/ .49 93

    90 -44/ ;08808 8 90 2489 .42243

    ,-3472,9 41 420489,88

  • 8/14/2019 Lecture 19 - Anticoagulants

    5/43

    7907, 9742-488 2, 708:9

    3 8.02. 30.7488 41 90 988:0 8:550/

    - 90 ,7907

    3 0,250 8 24.,7/, 31,7.943 /:0

    94 4..:843 41 90 .4743,7 ,790708

  • 8/14/2019 Lecture 19 - Anticoagulants

    6/43

    '034:8 9742-488 2, .,:80 988:08

    /7,30/ - 90 ;03 94 -0.420 0/02,94:8

    ,3/ 31,20/

  • 8/14/2019 Lecture 19 - Anticoagulants

    7/43

    %$

    %0 .4,:,943 574.088 9,9 0307,908

    9742-3 .438898 41 94 390770,90/ 5,9,8

    , 09738. 5,9,

    - 39738. 5,9,

  • 8/14/2019 Lecture 19 - Anticoagulants

    8/43

    %009738.88902 839,90/-90

    ,.9;,94341.49931,.947'

    ,3/90700,8041988:09742-45,893 ,

    548545/,3/57490329:70

  • 8/14/2019 Lecture 19 - Anticoagulants

    9/43

    %039738.88902 897070/03-44/

    .42083.439,.9905480/.4,03

    1-7083908:-03/490:241/,2,0/

    -44/;08808

  • 8/14/2019 Lecture 19 - Anticoagulants

    10/43

    39738.5,9, 9738.5,9,

    ,

    ,

    ,

    ,

    !

    ,

    '

    ,

    ,

    !

    '

    ,

    ', '

    422435,9,

    !749742-31,.947 %742-3

    ,-73403 -73

    $9,-01-7354207

  • 8/14/2019 Lecture 19 - Anticoagulants

    11/43

    49889028,.9;,901,.94797,3814723

    939490,.9;01472,.903

    .43;07985749742-33949742-3

    %013,89053905,9,890

    .43;07843-1,.947,411-734033941-73

  • 8/14/2019 Lecture 19 - Anticoagulants

    12/43

    %&%$

    %4 9508 41 /7:8 ,70 02540/ 3

    570;0393 -44/ .4,:,943 05,73 ,3/

    90 ;9,23 ,39,43898

    %07 20.,3828 41 ,.943

    /1107 ,8 /4 907 .3., :808

  • 8/14/2019 Lecture 19 - Anticoagulants

    13/43

    /4+62

    05,73 8 , 7,5/ ,.93 ,39.4,:,39

    05,73 4..:78 3472, .42500/ 94

    89,230 3 2,89 .08

    9 8 89743 ,./.

  • 8/14/2019 Lecture 19 - Anticoagulants

    14/43

    /-+27 30 -832

    05,73 3.70,808 ,.9;9 41 ,399742-3

    . 3-98 ,.9;,90/ 80730 57490,808

    8:. ,8 , 9742-3 , , , ,

    ,3/ , 3 90 .4993 .,8.,/0

  • 8/14/2019 Lecture 19 - Anticoagulants

    15/43

    05,73 14728 , 9073,7 .4250 9

    ,399742-3 ,3/ 90 .4993 1,.9478

    %0 .4993 1,.9478 ,70 3,.9;,90/ ,3/

    05,73 8 700,80/ 1742 90 .4250

  • 8/14/2019 Lecture 19 - Anticoagulants

    16/43

    05,73 ,84 ,8 , /70.9 ,39.4,:,39

    ,.9;9 ,8 /0243897,90/ - 98 0110.9;03088

    3 ;974

    05,73 700,808 54574903 5,80 1742

    ;,8.:,7 -0/8 ,..007,908 .0,73 41

    545749038 1742 90 5,82,

  • 8/14/2019 Lecture 19 - Anticoagulants

    17/43

    %0,39.4,:,390110.94105,738

    220/,90,3/2,2,,39.4,:,943

    4..:789323:908,1907/70.9397,;034:8

    05,7330.943

  • 8/14/2019 Lecture 19 - Anticoagulants

    18/43

    $/6+4/98- 97/7

    5704507,9;0 5745,8 ,,389 /005

    ;03 9742-488

    3 ,.:90 24.,7/, 31,7.943

    94 570;039 5:243,7 02-482 3 5,90398

    9 089,-80/ 9742-488

    94 570;039 .4993 3 097,.475470,

    .7.:,943 /0;.08

  • 8/14/2019 Lecture 19 - Anticoagulants

    19/43

    05,73 .,3 -0 ;03 0907 ,8 , .4393:4:8

    31:843 47 - 3907299039 30.9438

    9 .,3 ,84 -0 ;03 ,8 /005 8:-.:9,304:8

    30.9438

  • 8/14/2019 Lecture 19 - Anticoagulants

    20/43

    05,73 8 9,03 :5 - 90 709.:403/490,

    88902 ,3/ :3/07408 05,9. /07,/,943

    94 3,.9;0 574/:.98

    %0701470 9 ,8 , 4307 ,110 3 5,90398

    9 05,9. .77488

  • 8/14/2019 Lecture 19 - Anticoagulants

    21/43

    .:/67//00/-87

    , 00/3.425.,943802477,0.,3

    -0.439740/-;35749,2308:5,90

    ,-,8.8:-89,3.0!749,230-3/89994

    ,3/30:97,0890,39.4,:,39

    0110.94105,73

  • 8/14/2019 Lecture 19 - Anticoagulants

    22/43

    .:/67//00/-87-328.

    - 50780389;970,.943810;07,3,5,8

    . %742-4.94503,

    / 89045474889439072970,92039

  • 8/14/2019 Lecture 19 - Anticoagulants

    23/43

    '+60+62

    ,71,73 8 , .4:2,73 /07;,9;0

    34907 0,250 8 /.4:2,74

    %080 ,39.4,:,398 ,.9 - ,39,433

    '9 . 8 088039, 147 90 839088

    41 , 3:2-07 41 .4993 1,.9478 3.:/3

    ,.9478 '

  • 8/14/2019 Lecture 19 - Anticoagulants

    24/43

    &30 05,73 90 ,39.4,:,39 0110.9 41

    ,71,73 ,3/ 70,90/ .4254:3/8 ,70 349

    4-807;0/ :39 4:78 ,1907

    /7: ,/23897,943

  • 8/14/2019 Lecture 19 - Anticoagulants

    25/43

    ,71,73 8 47, ,.9;0 -4,;,,-9 8

    ,1907 47, ,/23897,943

    9 8 09038;0 -4:3/ 94 5,82, 5749038

    ,3/ .,3 /85,.0 2,3 4907 /7:8 1742

    98 890

  • 8/14/2019 Lecture 19 - Anticoagulants

    26/43

    .:/67/ /00/-87

    -00/3

    02477,. 31,7.943 3 90 -70,89

    3908930 ,3/ 1,99 988:08

  • 8/14/2019 Lecture 19 - Anticoagulants

    27/43

    ,71,73 70,/ .748808 90 5,.039, ,3/

    .,3 .,:80 02477,0 3 90 109:8

    9 8 90701470 .4397, 3/.,90/ 3 5703,3.

  • 8/14/2019 Lecture 19 - Anticoagulants

    28/43

    691 28/6+-8327

    9070 ,70 , 3:2-07 41 /7:8 9,9 549039,90

    90 ,39.4,:,39 0110.9 41 ,7,1,73 8:. ,8

    ,.:90 ,.44 394.,943 .209/30

    503-:9,430 0 49078 ,9903:,90

    90 ,39.4,:,39 0110.9 41 ,7,1,73

    8:. ,8 .743. ,.44 308943

    -,7-9:7,908 71,25.3

  • 8/14/2019 Lecture 19 - Anticoagulants

    29/43

    $"$ "%#

    -73 .498 ,70 /884;0/ - 90 0320

    5,823

    3 ;;4 3,.9;0 5,823403 8 .43;0790/ 94

    5,823 - 988:0 5,823403 ,.9;,947

    9!

  • 8/14/2019 Lecture 19 - Anticoagulants

    30/43

    .:90 9742-402-4. /80,80 2, -0

    970,90/ - 90 ,/23897,943 41 ,0398 9,9

    ,.9;,90 90 .43;07843 41 5,823403 94

    5,823 , 80730 57490,80 9,9 /74808

    1-73 ,3/ 9:8 /884;08 .498

    ,2508$9705943,80 :743,80 ,3/

    988:0 950 5,823403 ,.9;,947 9!

  • 8/14/2019 Lecture 19 - Anticoagulants

    31/43

    #86/4832+7/

    $9705943,80 8 ,3 097,.0:,7 574903

    /07;0/ 1742 8970594.4..

  • 8/14/2019 Lecture 19 - Anticoagulants

    32/43

    /-+27 30 +-832

    9 -3/8 94 5,823403 ,3/ .,9,08 90

    .43;07843 41 5,823403 94 ,.9;0 5,823

    9 ,.98 43 -49 1-73-4:3/ ,3/

    .7.:,93 5,823403

  • 8/14/2019 Lecture 19 - Anticoagulants

    33/43

    $/6+4/98- 97/7

    3 ,.:90 5:243,7 02-482 /005 ;03

    9742-488 ,.:90 24.,7/, 31,7.943

    ,7907, 9742-488 ,3/ 4..:/0/

    507507, ,790708

  • 8/14/2019 Lecture 19 - Anticoagulants

    34/43

    +6+-32/8-

    $9705943,80 907,5 8 3899:90/ 93

    4:78 41 , 24.,7/, 31,7.943 ,3/

    .4393:0/ 147 94 /,8

    .:/67/ /00/-87

    , 00/3 /847/078

    - 50780389;9

  • 8/14/2019 Lecture 19 - Anticoagulants

    35/43

    %632+7/

    9 ,8 473, 4-9,30/ 1742 :730 -:9

    8 34 4-9,30/ 1742 .:9:70/ /30 .08

    /-+27 30 +-832

    ,9,08 90 .43;07843 41 5,823403

    94 5,823 9 ,.98 43 -49 1-73-4:3/ ,3/

    .7.:,93 5,823403

  • 8/14/2019 Lecture 19 - Anticoagulants

    36/43

    $/6+4/98- 97/7

    3 ,.:90 5:243,7 02-482 /005 ;03

    9742-488 ,.:90 24.,7/, 31,7.943

    ,7907, 9742-488 ,3/ 4..:/0/

    507507, ,790708

    9 8 :801: 3 5,90398 80389;0 94

    89705943,80

  • 8/14/2019 Lecture 19 - Anticoagulants

    37/43

    .:/67/ /00/-87

    00/3 .425.,9438 ,70 90 2489

    25479,39 8/0 0110.98

  • 8/14/2019 Lecture 19 - Anticoagulants

    38/43

    $779/ 84/ +7231/2 +-8:+836

    9 8 ,3 03/4034:8 57490,80

    /-+27 30 +-832

    9! 7,5/ ,3/ 570107039, ,.9;,908

    1-73-4:3/ 5,823403

    9 ,8 , 847907 ,110 9,3 89705943,80

    ,3/ :743,80 0,/3 94 290/ 88902.

    ,/;0780 0110.98

  • 8/14/2019 Lecture 19 - Anticoagulants

    39/43

    $/6+4/98- 97/7

    4.,7/, 31,7.943

    .:/67/ /00/-87

    00/3 .425.,9438

  • 8/14/2019 Lecture 19 - Anticoagulants

    40/43

    $$$ "%#

    %080 3.:/0

    .4403,80 3-9478 ,8573 09.

    %0 ,70 :80/ 3 :389,-0 ,33, ,3/

    24.,7/, 31,7.943

  • 8/14/2019 Lecture 19 - Anticoagulants

    41/43

    3-9478 41 ! 70.05947 ,.9;9 09.45/30 .45/470

    ! 70.05947 ,.9;,943 8 30,9;0 .4:50/

    94 ,/03 ..,80 %0 ,70 :80/ 3 :389,-0

    ,33, ,3/ 3 5,90398 9 97,38039 8.,02.

    ,99,.8 %.45/30 8 8:9,-0 3 5,90398 4

    .,3349 9407,90 ,8573

  • 8/14/2019 Lecture 19 - Anticoagulants

    42/43

    57/,240.4743,7;,84/,947

    93-985,900954854/08907,80,.9;9

    9,843-98839088419742-4,308,3/549039,90900110.94157489,..3

    097,3 3-985,90091:3.943,3/

    1-7354207,943

  • 8/14/2019 Lecture 19 - Anticoagulants

    43/43

    4,:,943,8.,/0